Onderneming Shanghai Junshi Biosciences Co., Ltd. Deutsche Boerse AG
Aandelen
8SJ
CNE100003FF7
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,39 EUR | +3,73% | +1,46% | -46,54% |
Vakgebied
Aantal werknemers: 2 568
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Drugs
100,0
%
| 1 690 | 100,0 % | 1 660 | 100,0 % | -1,77% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
78,8
%
| 875 | 61,2 % | 1 284 | 78,8 % | +46,70% |
Overseas
21,2
%
| 554 | 38,8 % | 345 | 21,2 % | -37,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jianjun Zou
CEO | Chief Executive Officer | 52 | 20-04-22 |
Zhuo Bing Zhang
FOU | Founder | 56 | 27-12-12 |
Cong Li
CEO | Chief Executive Officer | 60 | 22-12-16 |
Bao Hong Xu
DFI | Director of Finance/CFO | 45 | 01-11-20 |
Jun Xiong
CHM | Chairman | 50 | 27-03-15 |
Patricia Keegan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gang Wang
BRD | Director/Board Member | 67 | 29-08-19 |
Ning Li
BRD | Director/Board Member | 63 | 08-01-18 |
Sheng Yao
BRD | Director/Board Member | 48 | 01-06-14 |
Hui Feng
BRD | Director/Board Member | 48 | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roy Herbst
BRD | Director/Board Member | 60 | 24-06-18 |
Cong Li
CEO | Chief Executive Officer | 60 | 22-12-16 |
Yi Tang
BRD | Director/Board Member | 56 | 30-05-15 |
Jun Xiong
CHM | Chairman | 50 | 27-03-15 |
Hui Feng
BRD | Director/Board Member | 48 | 01-01-14 |
Sheng Yao
BRD | Director/Board Member | 48 | 01-06-14 |
Zhuo Bing Zhang
FOU | Founder | 56 | 27-12-12 |
Ning Li
BRD | Director/Board Member | 63 | 08-01-18 |
Xiao Yuan Feng
BRD | Director/Board Member | 67 | 16-12-21 |
An Ming Meng
BRD | Director/Board Member | 60 | 30-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 766 394 171 | 0 | 679 027 ( 0,0886 %) | 15,17 % |
Aandeel B | 1 | 219 295 700 | 149 560 900 ( 68,20 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
2 000 000 | 0.46% | 7 413 040 $ |
Bedrijfsgegevens
Shanghai Junshi Biosciences Co., Ltd.
13th Floor, Building 2 No. 36 & 58 Haiqu Road
201203, Shanghai
+
http://www.junshipharma.comSector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,12% | 92,26 mld. | |
-2,63% | 38,11 mld. | |
-12,43% | 32,9 mld. | |
+66,54% | 26,51 mld. | |
-13,02% | 15,75 mld. | |
-5,70% | 13,36 mld. | |
-10,50% | 11,65 mld. | |
-49,11% | 10,12 mld. | |
+187,82% | 9,78 mld. |
- Beurs
- Aandelen
- Koers 1877
- Koers 8SJ
- Onderneming Shanghai Junshi Biosciences Co., Ltd.